Global Breast Cancer Brachytherapy Market Size & Outlook
Global breast cancer brachytherapy market, 2015-2027 (US$M)
Related Markets
Global breast cancer brachytherapy market highlights
- The global breast cancer brachytherapy market generated a revenue of USD 58.4 million in 2018 and is expected to reach USD 105.3 million by 2027.
- The market is expected to grow at a CAGR (2019 - 2027) of 6.8% by 2027.
- In terms of segment, high dose rate (hdr) accounted for a revenue of USD 38.7 million in 2018.
- High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2018.
- Country-wise, U.S. is expected to register the highest CAGR from 2019 to 2027.
Global data book summary
| Market revenue in 2018 | USD 58.4 million |
| Market revenue in 2027 | USD 105.3 million |
| Growth rate | 6.8% (CAGR from 2018 to 2027) |
| Largest segment | High dose rate (hdr) |
| Fastest growing segment | High Dose Rate (HDR) |
| Historical data covered | 2015 - 2017 |
| Base year for estimation | 2018 |
| Forecast period covered | 2019 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High Dose Rate (HDR), Low Dose Rate (LDR) |
Other key industry trends
- In terms of revenue, the North America accounted for 50.7% of the global breast cancer brachytherapy market in 2018.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 44.4 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Brachytherapy Market Scope
Breast Cancer Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global breast cancer brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.
High dose rate (hdr) was the largest segment with a revenue share of 66.27% in 2018. Horizon Databook has segmented the Global breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2015 to 2027.
- Global Breast Cancer Brachytherapy Technology Outlook (Revenue, USD Million, 2015-2027)
- High Dose Rate (HDR)
- Low Dose Rate (LDR)
Reasons to subscribe to Global breast cancer brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global breast cancer brachytherapy market databook
-
Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global breast cancer brachytherapy market, including forecasts for subscribers. This global databook contains high-level insights into Global breast cancer brachytherapy market from 2015 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Global breast cancer brachytherapy market size, by regions, 2015-2027 (US$M)
Top 10 countries: Breast cancer brachytherapy market size, 2018 (US$M)
Global breast cancer brachytherapy market share, by technology, 2018 & 2027 (%, US$M)
Breast cancer brachytherapy market: Opportunity assessment by country
Global breast cancer brachytherapy market, by region, 2018 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
